Annexon Inc (NAS:ANNX)
$ 5.39 0.05 (0.94%) Market Cap: 574.54 Mil Enterprise Value: 264.03 Mil PE Ratio: 0 PB Ratio: 1.72 GF Score: 40/100

Annexon Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript

Jun 23, 2021 / 05:20PM GMT
Release Date Price: $23.91 (-0.33%)
Steve Seedhouse
Raymond James Financial - Analyst

Terrific. Well, good afternoon, good morning to those on the West Coast. Welcome to the next session of the Raymond James Human Health Innovation Conference. I'm Steve Seedhouse. Really, it is a pleasure for me to welcome the next participating company to this session, Annexon. And joining us in presenting on behalf of Annexon, of course, is CEO, Doug Love. Very much looking forward to the presentation. Thanks so much for being at the conference this year. And with that, Doug, I'll cede the floor and the microphone to you.

Doug Love
Annexon, Inc. - President & CEO

Thank you so much, Steve. A real pleasure to be speaking with you this morning and thank all of you for joining us this morning as well. We're excited to share an update on Annexon Biosciences, a lot of good things going on around the company. I will fast-forward through slide 2, our forward-looking statements, but invite you to review those on our website at your leisure.

And turning to slide 3, as many of you know, Annexon is on a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot